查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1265633

新一代定序(NGS)樣品製作的全球市場

Next Generation Sequencing (NGS) Sample Preparation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 88 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

新一代定序(NGS)樣品製作相關的全球市場在2030年前將達到94億美元

在COVID-19後改變的商務環境中，2022年27億美元的新一代定序(NGS)樣品製作相關的全球市場，在2030年前將達到94億美元的規模，在2022年～2030年預計將以年複合成長率17％增長。本報告所分析之市場區隔之一的試劑·消耗品年複合成長率將記錄19％，到分析期間結束時將達到62億美元。考慮疫情後的復甦，工作站領域今後8年的年複合成長率將修正為13.8％。

美國市場估算為7億8,830萬美元，中國則將以年複合成長率15.9％增長

關於美國的新一代定序(NGS)樣品製作市場在2022年估算為7億8,830萬美元。作為世界第2大經濟大國的中國，在2022年～2030年年複合成長率預計將為15.9％，在2030年前將達到16億美元的市場規模。其他熱門的地區市場有日本和加拿大，在2022年～2030年預計將各以14.6％和13.7％的速度成長。在歐洲市場中，德國以年複合成長率10.9％成長。

調查對象企業範例

  • Agilent Technologies
  • Beckman Coulter(A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP22379

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach $9.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$2.7 Billion in the year 2022, is projected to reach a revised size of US$9.4 Billion by 2030, growing at aCAGR of 17% over the period 2022-2030. Reagents & Consumables, one of the segments analyzed in the report, is projected to record 19% CAGR and reach US$6.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Workstations segment is readjusted to a revised 13.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $788.3 Million, While China is Forecast to Grow at 15.9% CAGR

The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$788.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.6% and 13.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.

Select Competitors (Total 32 Featured) -

  • Agilent Technologies
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Next Generation Sequencing (NGS) Sample Preparation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Semi-Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 2: World 10-Year Perspective for Semi-Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for NGS Library Preparation Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 4: World 10-Year Perspective for NGS Library Preparation Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 6: World 10-Year Perspective for Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clonal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 8: World 10-Year Perspective for Clonal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 10: World 10-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 12: World 10-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 14: World 10-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Metagenomics, Epidemiology & Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 16: World 10-Year Perspective for Metagenomics, Epidemiology & Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agrigenomics & Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 18: World 10-Year Perspective for Agrigenomics & Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for HLA Typing / Immune System Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 20: World 10-Year Perspective for HLA Typing / Immune System Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 22: World 10-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 24: World 10-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 26: World 10-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Pharma & Biotech Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 28: World 10-Year Perspective for Pharma & Biotech Entities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 30: World 10-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 31: World Next Generation Sequencing (NGS) Sample Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 33: World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 35: World 10-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Workstations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 37: World 10-Year Perspective for Workstations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2021 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 39: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 41: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 43: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 45: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 47: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 49: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 51: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 53: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • JAPAN
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2021 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 55: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 57: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 59: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 61: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • CHINA
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2021 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 63: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 65: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 67: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 69: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • EUROPE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2021 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 71: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 73: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 75: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 77: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 79: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • FRANCE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2021 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 81: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 83: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 85: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 87: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • GERMANY
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2021 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 89: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 91: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 93: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 95: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 97: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 99: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 101: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 103: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • UNITED KINGDOM
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2021 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 105: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 107: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 109: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 111: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • ASIA-PACIFIC
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2021 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 129: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 131: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 133: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 135: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030

IV. COMPETITION